Nefirin Capsule 150 mg (Pregabalin)

Adult dose

This medication, Pregabalin, is administered orally in divided doses of the total daily dose twice a day, regardless of food intake. 1. Neuropathic pain 1) Peripheral neuropathic pain - Starting dose: 150 mg per day - May increase to 300 mg per day after 3 to 7 days. - Further may be increased up to a maximum of 600 mg per day at 7-day intervals if necessary. 2) Central neuropathic pain - Starting dose: 150 mg per day

Child dose

Safety and efficacy data are insufficient for children under 12 years and adolescents aged 12-17 years, hence administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so if you experience any mood or behavioral changes while taking it, you should consult a doctor immediately. It should not be administered to patients with hypersensitivity to this drug or specific hereditary diseases such as lactose intolerance. Diabetic patients may need to adjust their blood sugar control medications due to weight gain, so caution is advised. If symptoms of angioedema, such as swelling around the face or mouth, occur, the medication should be discontinued immediately. Elderly patients are at risk of falls due to dizziness or drowsiness, so they should be particularly cautious when starting the medication. Temporary blurred vision or changes in vision may occur, but symptoms may improve after discontinuation of the drug. Discontinuing this medication suddenly may lead to withdrawal symptoms such as insomnia, headache, and anxiety, so it should be tapered off according to a doctor's instructions. There is a risk of drug abuse, so patients with a history of drug abuse should be more cautious. Patients with decreased kidney function may require dosage adjustment. Patients with heart disease should be vigilant for symptoms of heart failure while taking this medication. Taking this medication with other drugs that have central nervous system depressant effects may increase the risk of drowsiness or respiratory depression. In early pregnancy, there may be a risk of fetal malformations, so use during pregnancy must be approached with caution, and effective contraception is advised for women of childbearing age. During breastfeeding, because this medication may be transmitted through breast milk, a discussion with a doctor is necessary regarding whether to discontinue breastfeeding or the medication. This medicine can cause dizziness and drowsiness, so driving or operating dangerous machinery should be avoided until symptoms are confirmed. If severe skin rashes or allergic reactions occur, discontinue use immediately and notify healthcare personnel. In case of overdose, confusion, drowsiness, seizures, etc., may occur, and appropriate treatment should be sought in a hospital if necessary. Keep out of reach of children and do not transfer to another container for safety.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, cough with fever and respiratory abnormalities, yellowing of skin or eyes, profound lethargy, sudden and severe headache, lightning headache, seizures, altered consciousness, visual disturbances, paralysis, significantly reduced urine production

Mild side effects

• Dizziness
• drowsiness
• confusion
• spatial disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly closed container to avoid exposure to air and moisture. Additionally, it is important to store it at room temperature between 15 and 30 degrees Celsius to maintain its effectiveness.

Appearance

A hard capsule with a white upper part and a white lower part containing a white powder that is white or pale yellow.

Package unit

30 capsules/bottle, 200 capsules/bottle